Dow Up Triple Digits, Poised to Snap Three-Day Skid

The Nasdaq and S&P 500 both hit record intraday highs

Digital Content Manager
Sep 2, 2021 at 12:02 PM
facebook X logo linkedin


The Dow Jones Industrial Index (DJI) is staging a bounce off yesterday's lukewarm trading, last seen up 150 points and set to snap a three-day losing streak. The Nasdaq Composite (IXIC) and S&P 500 Index (SPX) are sporting notable gains of their own, after both hitting record intraday highs earlier in the session. Upbeat jobless claims that came in at pandemic-era lows are putting some wind at the market's back. Elsewhere, Wall Street's "fear gauge," the Cboe Volatility Index (VIX) is eyeing its lowest close in nearly three weeks. 

Continue reading for more on today's market, including: 

  • Workhorse stock is brushing off yesterday's SEC drama. 
  • Wall Street is responding to Five Below's mixed earnings report
  • Plus, drug stock eyes FDA warning; a soaring satellite stock; and  a penny stock hitting new lows. 

MMC stats spet 2

Options traders are piling on drug stock AbbVie Inc (NYSE:ABBV) today. So far, 11,000 calls and 6,491 puts have exchanged hands, which is three times the intraday average. The most popular is the weekly 115-strike call, followed by the September 120 call. The U.S. Food and Drug Administration (FDA) just issues new warnings on AbbVie's arthritis drug, along with several others including drugs from Pfizer (PFE) and Eli Lilly (LLY). SVB Leerink slashed its price target to $142 from $148 in response. ABBV is muted at midday, up 0.2% at $112.52, despite hitting a four-year peak of $121.53 during yesterday's trading. 

One of the best performing stocks on the New York Stock Exchange (NYSE) today is Globalstar, Inc. (NYSE:GSAT). The equity was last seen up 16.4% at $2.20 amid news the satellite services company received an advanced payment of $37.5 million from a customer. The stock enjoyed an incredible 64.3% jump on Monday after a major satellite update from Apple (AAPL). GSAT is up 570% in 2021.

Assembly Biosciences Inc (NASDAQ:ASMB) is one of the worst performing stocks on the Nasdaq today, last seen down 16.5% at $3.25. Weighing on the equity is news that the company scrapped the development of its experimental hepatitis B treatment, ABI-H2158, citing liver toxicity issues. ASMB touched a fresh record low of $3.09 right out of the gate, breaching its 10-day moving average after earlier this week getting rejected by its longer-term 120-day moving average.

asmb chart sept 2

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI